Latest Dishman Carbogen Amcis stock price
Dishman Carbogen Amcis P/E Ratio
DCAL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
29.78
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
29.78
Current Price
₹257.98
EPS (TTM)
₹0.21
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
20.93
Historical Range
7.4 - 35.43
Percentile
66.7%
Sector Context
Sector Average
53.58
Sector Median
31.12
Sector Rank
#11 of 131
Sector Percentile
8.4%
Earnings Breakdown (TTM)
TTM EPS
₹10.51
Sept 2025
₹4.16
Mar 2025
₹2.75
Key P/E Ratio Insights for Dishman Carbogen Amcis
- Stock appears overvalued with PE of 29.78, suggesting caution for new investments
- Current PE is 42.3% above historical average
- Trading at discount to sector average PE of 53.58
View the DCAL equity price for detailed stock performance.
P/E Ratio Historical Trend for Dishman Carbogen Amcis
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Dishman Carbogen Amcis
Additional stock information and data for DCAL
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2019 | 7.4 | 11.42 | ₹84.55 | BSE | Low |
| 2018 | 19.97 | 11.54 | ₹230.40 | BSE | Moderate |
| 2017 | 35.43 | 9.06 | ₹321.00 | BSE | High |
Sector P/E Ratio Comparison
Comparing Dishman Carbogen Amcis with other companies in Healthcare sector
Sector Average
53.58
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |